On Jan. 11, 2021, TheNew York Times posted an article about the virtues of fecal immunochemical testing relative to colonoscopy. The story, “A Colonoscopy Alternative Comes Home” [https://www.nytimes.com/ 2021/ 01/ 11/ health/ colonoscopy-health-home-testing.html] depicted colonoscopy as a comparatively risky procedure with few advantages over less invasive methods of testing for colorectal cancer. It also offered the speculation that financial factors— namely, greater reimbursement for endoscopy—was behind the general preference of gastroenterologists for colonoscopy over stool tests.
Trending
- Exact Sciences and Lil Jon Partner on “Get Low #2” Campaign to Encourage Colon Cancer Screening (Business Wire)
- AI Tool Identifies Undiagnosed Early-Stage MASLD (MDedge)
- Joining forces to develop a multidisciplinary care model in GI (Takeda)
- Zepbound sheds more weight than Wegovy in trial, Eli Lilly says (NBC News)
- Cheap, non-invasive tool that detects bowel disease coming in 2027: Hong Kong scientists (South China Morning Post)
- Some Older Adults Think Stopping CRC Screening at Age 75 Is ‘Unacceptable’ (MedPage Today)
- Why Operators Are Embracing Hybrid ASC, Office-Based Lab Models (ASC News)
- This year, be thankful for AI in medicine (The Washington Post)